CNB Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

CNB Bank’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.49K	Hold	4	–	–	﹤0.01%	479
2026 Q1	$3.09K	Hold	4	–	–	﹤0.01%	476
2025 Q4	$3.09K	Hold	4	–	–	﹤0.01%	464
2025 Q3	$2.25K	Hold	4	–	–	﹤0.01%	470
2025 Q2	$2.1K	Hold	4	–	–	﹤0.01%	454
2025 Q1	$2.54K	Hold	4	–	–	﹤0.01%	438
2024 Q4	$2.85K	Hold	4	–	–	﹤0.01%	442
2024 Q3	$4.21K	Hold	4	–	–	﹤0.01%	450
2024 Q2	$4.2K	Hold	4	–	–	﹤0.01%	441
2024 Q1	$3.85K	Hold	4	–	–	﹤0.01%	431
2023 Q4	$3.51K	Hold	4	–	–	﹤0.01%	424
2023 Q3	$3.29K	Hold	4	–	–	﹤0.01%	428
2023 Q2	$2.87K	Hold	4	–	–	﹤0.01%	394
2023 Q1	$3.29K	Hold	4	–	–	﹤0.01%	417
2022 Q4	$2.89K	Hold	4	–	–	﹤0.01%	390
2022 Q3	$3K	Hold	4	–	–	﹤0.01%	403
2022 Q2	$2K	Hold	4	–	–	﹤0.01%	423
2022 Q1	$3K	Hold	4	–	–	﹤0.01%	415
2021 Q4	$3K	Buy	+4	New	+$2.46K	﹤0.01%	403

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

CNB Bank's REGN Position: Q2 2026 in Review

CNB Bank held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 4 shares worth $2.49K. The position accounts for ﹤0.01% of the portfolio, ranked #479.

CNB Bank first reported a position in REGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.21K in Q3 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

CNB Bank held 4 shares of Regeneron Pharmaceuticals worth $2.49K as of Q2 2026.
CNB Bank left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
Regeneron Pharmaceuticals made up ﹤0.01% of CNB Bank's portfolio in Q2 2026, its #479 holding.
CNB Bank first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
CNB Bank's Regeneron Pharmaceuticals position peaked at $4.21K in Q3 2024.
1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on CNB Bank's 13F filing for Q2 2026, filed 6 Aug 2026.